No Data
No Data
Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) Stock Price Dropped 12% Last Week; Retail Investors Would Not Be Happy
Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
BURLINGAME, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive
13 Penny Stocks With Insider Buying in 2024
Insider Spends US$1m Buying More Shares In Corvus Pharmaceuticals
Express News | Steven Cohen Reports 9.9% Passive Stake in Corvus Pharmaceuticals Inc as of May 2 - SEC Filing
Corvus Pharmaceuticals | 10-Q: Quarterly report
No Data